Skip to main content

Specimen Collection Manual and Test Catalog

  or
  or
  or

FIBRINOGEN

Geisinger Epic Procedure Code:  LAB2283    Geisinger Epic ID:  7170

SPECIMEN COLLECTION
Specimen type: 

Platelet-poor plasma


Preferred collection container: 
Alternate collection container: 
Other size blue-top (3.2% sodium citrate) tubes (e.g., 1.8 mL, 4.5 mL)
Specimen required: 

1 mL


Special notes: 
  • If the patient’s hematocrit (HCT) is >55%, the volume of anticoagulant in the tube must be adjusted. Contact a performing location for sodium citrate adjusted tubes or instruction for how to adjust the sodium citrate.
  • When possible, use fresh venipuncture.
  • Avoid prolong tourniquet time (< 1 minute) and hemolysis during collection as this will alter results.
  • If indwelling catheter or butterfly collection device must be used, draw sample from a non-heparinized lumen or flush the line with 5 mL of saline and discard the first 10 mL of blood.
  • Tubes should be >90% filled.
  • Immediately mix gently after collection by inverting the tube end over end 5 to 6 times. Avoid vigorous mixing or additional inversion. Observe for the presence of clots or hemolysis and recollect if observed.


SPECIMEN PROCESSING
Processing instructions: 

Centrifuge specimen immediately at designated time and speed to obtain platelet-poor plasma (<10,000/µL). Using a plastic pipette, carefully remove plasma from cells, avoiding platelet/buffy layer by leaving a thin layer of plasma on top the cells. The centrifuged plasma should be aliquoted (1 mL per aliquot) into clearly labeled polypropylene tubes. The number of tests ordered will determine the aliquots needed. Check the residual specimen for clot and if present discard sample and redraw specimen. If plasma is icteric, lipemic or hemolyzed a lab comment should be generated to notify staff. Freeze upright in non-thaw freezer.


Transport temperature: 

Plasma (on or off packed cells): Room temperature 
Plasma off cells: Frozen on dry ice


Specimen stability: 

Room temperature (plasma on cells): 4 hours 
Room temperature (plasma off cells): 8 hours 
Frozen (plasma) -20°C: 2 weeks 
Frozen (plasma) -70°C: 6 months


Rejection criteria: 

Clotted, hemolyzed, improperly filled tubes, improper anticoagulant ratio (HCT >55% and citrate not adjusted), refrigerated specimens, or stability exceeded.

Note: Specimen suspected of thawing in transport, indicated by slant in aliquot or specimen in lid of tube, will have testing performed, and the comment “interpret results with caution as thawing suspected” added to results.



TEST DETAILS
Reference interval: 

178-467 mg/dL


Critical values/courtesy alerts: 
<60 mg/dL
Additional information: 

Anticoagulation Impact on Coagulation Tests


CPT code(s):  85384
Note: The billing party has sole responsibility for CPT coding.  Any questions regarding coding should be directed to the payer being billed.
The CPT codes provided by GML are based on AMA guidelines and are for informational purposes only.

Test includes: 

Fibrinogen activity


Methodology: 
Clauss
Thrombin Clotting Rate Assay
Synonyms: 

Factor I


Clinical significance: 

A soluble plasma protein that is converted by thrombin to form an insoluble fibrin clot. It also plays a role in platelet activation and aggregation.

Hypofibrinogenemia, or low fibrinogen levels, may be congenital or acquired from bleeding, disseminated intravascular coagulopathy (DIC) or severe liver disease. Levels may be elevated in chronic inflammation, pregnancy, or early/moderate liver disease. Dysfibrinogenemia, or an abnormal fibrinogen protein, may result in bleeding or thrombosis. Dysfibrinogenemia may result in low levels using this methodology, therefore, if suspected recommend comparing results to a fibrinogen antigen level. In patients with dysfibrinogenemia the fibrinogen activity and fibrinogen antigen levels will be different.


Doctoral Director(s): 
Michelle Grant DO
Review Date:  03/04/2025

Performing Locations